ANI Pharmaceuticals, Inc. (ANIP)

80.92 +2.85 (+3.65%) USD  |  NASDAQ  |  Apr 17, 16:00
80.88 -0.04 (-0.05%) After-Hours: 20:00
More

ANI Pharmaceuticals Total Operating Expenses (% of Quarterly Revenues)

Total Operating Expenses (% of Quarterly Revenues) Chart

View Total Operating Expenses (% of Quarterly Revenues) for ANIP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (% of Quarterly Revenues) Benchmarks

View Total Operating Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Liquidia Corp. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
Indivior Pharmaceuticals, Inc. Upgrade
Replimune Group, Inc. --
ADMA Biologics, Inc. Upgrade